http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090083407-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2007-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42808b9c4c7df63a2e6d6b2d6a5e9a11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7a36077382c1a16019d75551860481a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d7b3586d737f4a651972e04420553a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f725067266fc6b51d7a74952f4e495c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d33f4c9ec58635b85a8c3aa3da59b5f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f96f51b5214f8089f8961d580d6cb2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d9c44b93ab28b2f11710c52724d40a6
publicationDate 2009-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20090083407-A
titleOfInvention Crystalline Form of Zoledronic Acid
abstract The present invention is directed to novel crystalline forms of poorly water-soluble salts of zoledronic acid, methods for preparing these crystalline forms, compositions containing these crystalline forms, and the use of these crystalline forms in diagnostic methods or therapeutic treatments of warm-blooded animals, in particular humans. It is about. The present invention provides a crystalline form of the free acid monohydrate of zoledronic acid, a method for producing a crystalline form of the free acid monohydrate of zoledronic acid, a composition containing the crystalline form of the free acid monohydrate of zoledronic acid, and a warm-blooded animal, In particular it relates to the use of crystalline forms of the free acid monohydrate of zoledronic acid in human diagnostic methods or therapeutic therapies.
priorityDate 2006-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24644
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450483989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22338741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23444217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448452169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450142066

Total number of triples: 33.